<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37832076</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>41</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Clinical manifestations and outcomes of coronavirus disease 2019 among pediatric liver transplant recipients in the delta and omicron variant pandemic: A retrospective study.</ArticleTitle><Pagination><StartPage>e35537</StartPage><MedlinePgn>e35537</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e35537</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000035537</ELocationID><Abstract><AbstractText>To determine the clinical manifestations and outcomes of the coronavirus disease 2019 (COVID-19) in children who underwent liver transplantation (LT). A retrospective study was conducted at a transplant center in Thailand to include LT recipients aged &lt; 18 years who had been infected with COVID-19. Out of a total of 54 children, there were 31 probable cases (57.4%) diagnosed using an antigen test kit and 23 confirmed cases (42.6%) diagnosed using polymerase chain reaction (14 children) or severe acute respiratory syndrome coronavirus 2 antigen (9 children). Approximately half of the children (25, 46.3%) received the BNT162b2 vaccine before the infection, with 3 and 2 doses in 5 and 18 children, respectively. While some had COVID-19 during the delta pandemic, most (46 children, 85.2%) were infected during the omicron pandemic, of which manifestations included fever (67.4%), cough (50%), and rhinorrhea (47.8%), and symptoms lasted approximately 3 days. None had severe diseases. All patients with mild-to-moderate disease were advised to continue the same immunosuppressive therapy as before the infection. Compared to unvaccinated children or children with one dose of the vaccine, fever was less common in those who received &#x2265; 2 doses (OR: 0.08; 95%CI: 0.01-0.57, adjusted for age and immunosuppressive types). Favipiravir was prescribed in most patients (90.7%). Only a few children had long COVID-19 or abnormal liver function tests lasting &gt; 1 month (4 children, 7.4%, both). Pediatric LT recipients with COVID-19 during the delta and omicron variant pandemic reported mild symptoms despite undergoing immunosuppressive therapy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Getsuwan</LastName><ForeName>Songpon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ramathibodi Excellence Center in Organ Transplantation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boonsathorn</LastName><ForeName>Sophida</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6027-0534</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaisavaneeyakorn</LastName><ForeName>Sujittra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butsriphum</LastName><ForeName>Napapat</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ramathibodi Excellence Center in Organ Transplantation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanpowpong</LastName><ForeName>Pornthep</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ramathibodi Excellence Center in Organ Transplantation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lertudomphonwanit</LastName><ForeName>Chatmanee</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ramathibodi Excellence Center in Organ Transplantation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treepongkaruna</LastName><ForeName>Suporn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ramathibodi Excellence Center in Organ Transplantation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000090982">BNT162 Vaccine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000090982" MajorTopicYN="N">BNT162 Vaccine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066027" MajorTopicYN="N">Transplant Recipients</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>13</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>13</Day><Hour>16</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37832076</ArticleId><ArticleId IdType="pmc">PMC10578722</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000035537</ArticleId><ArticleId IdType="pii">00005792-202310130-00036</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nathanielsz J, Toh ZQ, Do LAH, et al. . SARS-CoV-2 infection in children and implications for vaccination. Pediatr Res. 2022;93:1177&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9376896</ArticleId><ArticleId IdType="pubmed">35970935</ArticleId></ArticleIdList></Reference><Reference><Citation>Dechsupa S, Assawakosri S, Phakham S, et al. . Positive impact of lockdown on COVID-19 outbreak in Thailand. Travel Med Infect Dis. 2020;36:101802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7305760</ArticleId><ArticleId IdType="pubmed">32569811</ArticleId></ArticleIdList></Reference><Reference><Citation>Uansri S, Tuangratananon T, Phaiyarom M, et al. . Predicted impact of the lockdown measure in response to coronavirus disease 2019 (COVID-19) in greater Bangkok, Thailand, 2021. Int J Environ Res Public Health. 2021;18:12816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8657386</ArticleId><ArticleId IdType="pubmed">34886542</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaiyakulsil C, Sritipsukho P, Satdhabudha A, et al. . An epidemiological study of pediatric COVID-19 in the era of the variant of concern. PLoS One. 2022;17:e0267035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9012366</ArticleId><ArticleId IdType="pubmed">35427379</ArticleId></ArticleIdList></Reference><Reference><Citation>Assawakosri S, Kanokudom S, Suntronwong N, et al. . Omicron BA.1, BA.2 and COVID-19 booster vaccination. J Infect Dis. 2022;226:1480&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9383713</ArticleId><ArticleId IdType="pubmed">35481828</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt AA, Dargham SR, Loka S, et al. . Coronavirus disease 2019 disease severity in children infected with the omicron variant. Clin Infect Dis. 2022;75:e361&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047187</ArticleId><ArticleId IdType="pubmed">35404391</ArticleId></ArticleIdList></Reference><Reference><Citation>Anugulruengkitt S, Teeraananchai S, Chantasrisawad N, et al. . Clinical outcomes of pediatric COVID-19 in a tertiary care center in Bangkok, Thailand. IJID Regions. 2021;1:159&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8600753</ArticleId><ArticleId IdType="pubmed">35721777</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal N, Ovchinsky N, Foca M, et al. . COVID-19 infection in pediatric solid organ transplant patients. Pediatr Transplant. 2022;26:e14156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646513</ArticleId><ArticleId IdType="pubmed">34633125</ArticleId></ArticleIdList></Reference><Reference><Citation>Buescher G, Sebode M, Marjot T, et al. . SARS-CoV-2 in pediatric liver transplant recipients: The European experience. J Pediatr Gastroenterol Nutr. 2022;74:e41&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8788629</ArticleId><ArticleId IdType="pubmed">34654793</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuksel M, Akturk H, Mizikoglu O, et al. . A single-center report of COVID-19 disease course and management in liver transplanted pediatric patients. Pediatr Transplant. 2021;25:e14061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8237072</ArticleId><ArticleId IdType="pubmed">34076953</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Clinical management of COVID-19: living guideline, 15 September 2022: World Health Organization; 2022. Available at: https://who.int/iris/handle/10665/362783.</Citation><ArticleIdList><ArticleId IdType="pubmed">35917394</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020: World Health Organization; 2020. Available at: https://apps.who.int/iris/bitstream/handle/10665/332196/WHO-2019-nCoV-clinical-2020.5-eng.pdf?sequence=1&amp;isAllowed=y.</Citation></Reference><Reference><Citation>Stephenson T, Allin B, Nugawela MD, et al. . Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch Dis Child. 2022;107:674&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X-y, Lu Y-f, Xue F, et al. . SARS-CoV-2 BA.2 (Omicron) variant infection in pediatric liver transplanted recipients and cohabitants during 2022 Shanghai outbreak: a prospective cohort. Virol J. 2023;20:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9918817</ArticleId><ArticleId IdType="pubmed">36774503</ArticleId></ArticleIdList></Reference><Reference><Citation>Suntronwong N, Vichaiwattana P, Klinfueng S, et al. . SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: a longitudinal study. PLoS One. 2023;18:e0279147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10138857</ArticleId><ArticleId IdType="pubmed">37104299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak BO, Eun BW. COVID-19 in immunocompromised children and adolescents. Clin Exp Pediatr. 2023;66:182&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10167403</ArticleId><ArticleId IdType="pubmed">37070297</ArticleId></ArticleIdList></Reference><Reference><Citation>Minotti C, Tirelli F, Barbieri E, et al. . How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review. J Infect. 2020;81:e61&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179496</ArticleId><ArticleId IdType="pubmed">32335173</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman AG, Danziger-Isakov LA. The impact of COVID-19 on the pediatric solid organ transplant population. Semin Pediatr Surg. 2022;31:151178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9107330</ArticleId><ArticleId IdType="pubmed">35725046</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabu JM, Zahid I, Jacob N, et al. . Effectiveness of the BNT162b2 (Pfizer-BioNTech) vaccine in children and adolescents: a systematic review and meta-analysis. Vaccines. 2022;10:1880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9698079</ArticleId><ArticleId IdType="pubmed">36366387</ArticleId></ArticleIdList></Reference><Reference><Citation>Sintusek P, Buranapraditkun S, Khunsri S, et al. . Safety and humoral and cellular immunogenicity of the BNT162b2 SARS-CoV-2 vaccine in liver-transplanted adolescents compared to healthy adolescents. Vaccines. 2022;10:1324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9413008</ArticleId><ArticleId IdType="pubmed">36016212</ArticleId></ArticleIdList></Reference><Reference><Citation>Tubjaroen C, Prachuapthunyachart S, Potjalongsilp N, et al. . Immunogenicity of an mRNA-Based COVID-19 vaccine among adolescents with obesity or liver transplants. Vaccines. 2022;10:1867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9693317</ArticleId><ArticleId IdType="pubmed">36366375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Public Health. Thai Guidelines for COVID-19; 2022. 
[Cited 2023 June 14]. Available at: https://covid19.dms.go.th/backend///Content//Content_File/Covid_Health/Attach/25650422162203PM_CPG_COVID-19_n_v.22_20220422.pdf.</Citation></Reference><Reference><Citation>Udwadia ZF, Singh P, Barkate H, et al. . Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: a randomized, comparative, open-label, multicenter, phase 3 clinical trial. Int J Infect Dis. 2021;103:62&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668212</ArticleId><ArticleId IdType="pubmed">33212256</ArticleId></ArticleIdList></Reference><Reference><Citation>Golan Y, Campos JAS, Woolson R, et al. . Favipiravir in patients with early mild-to-moderate coronavirus disease 2019 (COVID-19): a randomized controlled trial. Clin Infect Dis. 2023;76:e10&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494366</ArticleId><ArticleId IdType="pubmed">36065065</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, He X, Wang Y, et al. . Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation. Hepatol Int. 2020;14:432&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146012</ArticleId><ArticleId IdType="pubmed">32277387</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin P, D&#xed;az LA, Mart&#xed;nez M, et al. . Acute liver injury among pediatric liver transplantation recipients with coronavirus disease 2019: an international collaborative study. J Pediatr Gastroenterol Nutr. 2021;73:391&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8373390</ArticleId><ArticleId IdType="pubmed">34183614</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarupan M, Jantarabenjakul W, Jaruampornpan P, et al. . Long COVID and hybrid immunity among children and adolescents post-delta variant infection in Thailand. Vaccines. 2023;11:884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10223729</ArticleId><ArticleId IdType="pubmed">37242988</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo del Valle NC, et al. . Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12:9950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>